Home ETFdb.com Biotech Maintains Disruptive Capabilities

Biotech Maintains Disruptive Capabilities

In what feels like an eternity in biotechnology terms, broader baskets of the industry’s stocks haven’t outperformed the S&P 500 Health Care Index annually since 2020.

newETFs.io respects the hard work of others and gives all credit to the remarkable folks at ETFdb.com. This excerpt/article was pulled from their RSS feed; click here to view the original. Please note that on occasion, the RSS feed will not have the author. When this happens this site defaults the author to "News". Make no mistake, this excerpt/article was not created by newETFs.io, it was simply shared with you.